Why the study?
Postoperative nausea and vomiting is a major complication occurring in up to 70% to 80% of high-risk patients after elective surgery under general anesthesia, making its prevention or reduction a major goal.
Does intravenous ondansetron plus dexamethasone reduce postoperative nausea and vomiting in patients undergoing elective surgeries under general anesthesia compared to ondansetron alone?
Does intravenous ondansetron plus dexamethasone reduce postoperative nausea and vomiting in patients undergoing elective surgeries under general anesthesia compared to ondansetron alone?
The combination of intravenous ondansetron and dexamethasone is superior to ondansetron alone in controlling postoperative nausea and vomiting, particularly delayed vomiting, after elective surgeries under general anesthesia.
Answers are grounded in this paper and cite their sources.
May support ondansetron-dexamethasone combination for PONV; leaves open need for confirmatory RCTs before practice change.
Background: PONV has been recognized as one of the major complications after elective surgeries under general anesthesia. The incidence of PONV can be as frequent as 70% to 80% in high risk groups, so prevention or reduction of PONV remains one of the major goals to be achieved. Aim & objective: The objective of this study is to compare the efficacy of intravenous ondansetron versus intravenous ondansetron plus dexamethasone combination in prevention / reduction of PONV after elective surgeries under general anesthesia with respect to early and delayed vomiting and their side effects. Methods: Our study was done in 100 patients, randomly divided into 2 groups of 50 patients each. One group received intravenous ondansetron 4mg while the other group received intravenous ondansetron 4mg plus dexamethasone 8mg 30 seconds before induction. Postoperatively patients were assessed hourly for 4 hours and then at 24 hours for degree of nausea, retching and vomiting, requirement of rescue antiemetic and side effects. Vomiting occurring upto 4 hours was considered as early and from 4-24 hours, as delayed vomiting. Results: Incidence of early and delayed nausea (20% each) was less in the combination group compared to ondansetron alone. Delayed vomiting was lower in the combination group compared to ondansetron alone. Conclusion: We hereby conclude that combination therapy of ondansetron and dexamethasone is superior and cost-effective in controlling PONV with delayed PONV being better controlled than early PONV compared to ondansetron alone.
No takes yet. Share an insight, caveat, or question.
Reddy et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: